Compare Docusign Inc (DOCU) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs Johnson & Johnson — how do they compare? Docusign Inc trades at $49.53 (market cap $9.52B), while Johnson & Johnson trades at $254.82 (market cap $620.51B). The key difference: Johnson & Johnson is far larger — about 65.2× Docusign Inc's market cap, and Johnson & Johnson pays a 2.08% dividend while Docusign Inc pays none. Which is the better fit depends on your goals.
| DOCU | JNJ | |
|---|---|---|
Market Cap | $9.52B | $620.51B |
Sector | Technology | Health |
52-Week High | $85.01 | $267.24 |
52-Week Low | $41.75 | $155.17 |
Enterprise Value | $8.89B | $653.44B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.08% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
